Skip to main content

Table 1 Patient characteristics

From: Assessment of the accuracy of biparametric MRI/TRUS fusion-guided biopsy for index tumor evaluation using postoperative pathology specimens

Age, median (interquartile range)

71 (66–74)

PSA, ng/ml, median (interquartile range)

8.7 (5.7–12.1)

prostate volume, ml, median (interquartile range)

28.9 (22.5–37.1)

median waiting time, day, median (interquartile range)

122 (100–161)

Pre-operative IT

PI-RADS 3, n (%)

20 (18%)

PI-RADS 4, n (%)

58 (51%)

PI-RADS 5, n (%)

35 (31%)

cT stage

cT2a, n (%)

32 (28%)

cT2b, n (%)

1 (0.9%)

cT2c, n (%)

38 (34%)

cT3a, n (%)

41 (36%)

cT3b, n (%)

1 (1.4%)

  1. Abbreviations: PSA prostate-specific antigen